---
figid: PMC6574129__nihms-1034285-f0005
figlink: /pmc/articles/PMC6574129/figure/F5/
number: Figure 5
caption: U2932 cells were treated with 50nM alisertib, 2.0μM ibrutinib and their combination
  for 4 days. Western blotting shows (A) Down regulation of the MAPK and PI3K/AKT
  pathways but up regulation of DNA damage response, (B) Single agent alisertib induces
  aneuploidy due to active mTOR/AKT and ERK/MAPK pathways. But combination therapy
  able to overcome aneuploidy and senescence illustrated in (C).
pmcid: PMC6574129
papertitle: Disruption of Aneuploidy and Senescence induced by Aurora inhibition promotes
  intrinsic Apoptosis in double hit or double expresser Diffuse Large B-cell Lymphomas.
reftext: Shariful Islam, et al. Mol Cancer Ther. 2017 Oct;16(10):2083-2093.
pmc_ranked_result_index: '116128'
pathway_score: 0.6277641
filename: nihms-1034285-f0005.jpg
figtitle: Aurora kinase plus BTK blockade inhibits the chronic active BCR pathway
  and induces apoptosis in DH/DE-DLBCL
year: '2017'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6574129__nihms-1034285-f0005.html
  '@type': Dataset
  description: U2932 cells were treated with 50nM alisertib, 2.0μM ibrutinib and their
    combination for 4 days. Western blotting shows (A) Down regulation of the MAPK
    and PI3K/AKT pathways but up regulation of DNA damage response, (B) Single agent
    alisertib induces aneuploidy due to active mTOR/AKT and ERK/MAPK pathways. But
    combination therapy able to overcome aneuploidy and senescence illustrated in
    (C).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TP53
  - AKT3
  - PARP16
  - PARP6
  - AKT2
  - AKT1
  - TNKS
  - PARP10
  - PARP2
  - PARP9
  - BCL2L1
  - GAPDH
  - TIPARP
  - PARP14
  - STAT2
  - STAT1
  - PARP11
  - PARP12
  - PARP8
  - TNKS2
  - BCL2
  - MAPK1
  - MAPK3
  - BCL6
  - PARP4
  - PARP15
  - SOS2
  - SOS1
  - STAT5A
  - STAT6
  - STAT3
  - STAT4
  - PARP1
  - STAT5B
  - SYK
  - PARP3
  - EIF2AK3
  - PLCG2
  - Ibrutinib
  - DMSO
  - Cancer
genes:
- word: p53)
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: p-Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP16
  entrez: '54956'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP6
  entrez: '56965'
- word: p-Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: p-Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS
  entrez: '8658'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP10
  entrez: '84875'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP2
  entrez: '10038'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP9
  entrez: '83666'
- word: Bcl-xL
  symbol: bcl-xL
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L1
  entrez: '598'
- word: GAPDH
  symbol: GAPDH
  source: hgnc_symbol
  hgnc_symbol: GAPDH
  entrez: '2597'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TIPARP
  entrez: '25976'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP14
  entrez: '54625'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP11
  entrez: '57097'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP12
  entrez: '64761'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP8
  entrez: '79668'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS2
  entrez: '80351'
- word: p-Bcl-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: p-ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: p-ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Bcl-6
  symbol: BCL6
  source: hgnc_symbol
  hgnc_symbol: BCL6
  entrez: '604'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP4
  entrez: '143'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP15
  entrez: '165631'
- word: (SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: (SOS
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP1
  entrez: '142'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: SYK
  symbol: SYK
  source: hgnc_symbol
  hgnc_symbol: SYK
  entrez: '6850'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP3
  entrez: '10039'
- word: p-ERK
  symbol: PERK
  source: hgnc_alias_symbol
  hgnc_symbol: EIF2AK3
  entrez: '9451'
- word: PLCY2)
  symbol: PLCG2
  source: hgnc_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
chemicals:
- word: Ibrutinib
  source: MESH
  identifier: C551803
- word: DMSO
  source: MESH
  identifier: D004121
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
